AssetID: 55099270
Headline: UNCAPTIONED: GSK Pledges $30 Billion US Investment As UK Pharma Struggles
Caption: GSK Pledges $30 Billion US Investment As UK Pharma Struggles. British drugmaker GSK has announced a massive 30 billion dollar investment in the United States over the next five years, funding new research and manufacturing facilities. The move was revealed as President Donald Trump began his state visit to the UK. GSK says the money will support next-generation factories, artificial intelligence tools, and new research labs across its American sites. About 1.2 billion dollars will go towards building a factory in Pennsylvania to produce medicines for cancer and respiratory diseases. Prime Minister Sir Keir Starmer called the investment a powerful example of US–UK collaboration, highlighting its potential to create jobs and accelerate drug development. But the pledge comes as Washington pressures pharmaceutical companies to shift production to the US with threats of tariffs on imports as high as 250 percent. GSK says it will still spend more than 1.5 billion pounds each year on research and development in Britain. But the company joins other firms scaling back UK investment, deepening concerns over the country’s pharmaceutical sector. Instructions: THIS VIDEO MUST NOT BE EDITED FOR LENGTH TO COMBINE WITH OTHER CONTENT
Keywords: Current Affairs & Politics,GSK,pledges,$30 billion,US investment,UK Pharmaceutical,struggles,British drugmaker,next five years,funding,new research,manufacturing facilities,President Donald Trump,state visit,United Kingdom,money,support,next-generation factories,AI,research labs,drugs
PersonInImage: